Clinical Trials Browser

HER2-positive Breast Cancer

Fallopian Tube Neoplasms, Ovarian Neoplasms

Carcinoma, Non-Small-Cell Lung

Lung Neoplasms

Lung Neoplasms

Carcinoma, Non-Small-Cell Lung

Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis

Lung Neoplasms

Ovarian Neoplasms

Neoplasm Metastasis

Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms

Esophageal Neoplasms

Squamous Cell Carcinoma of Head and Neck

Breast Neoplasms

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

Breast Neoplasms, Triple Negative Breast Neoplasms

Ovarian Neoplasms

Carcinoma, Non-Small-Cell Lung

Head and Neck Neoplasms

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

Carcinoma, Non-Small-Cell Lung

Breast Neoplasms

Squamous Cell Carcinoma of Head and Neck

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Esophageal Neoplasms

Breast Neoplasms

Cholangiocarcinoma

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

Breast Neoplasms, Ovarian Neoplasms

Uterine Cervical Neoplasms

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin

Brain Neoplasms, Breast Neoplasms, Central Nervous System Neoplasms, Drug-Related Side Effects and Adverse Reactions

Retinoblastoma

Breast Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Esophageal Neoplasms

Ovarian Neoplasms

Neuroblastoma, Retinoblastoma, Sarcoma, Central Nervous System Neoplasms, Choroid Plexus Neoplasms

Breast Neoplasms

Astrocytoma, Glioblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Carcinoma, Non-Small-Cell Lung

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung

Clinical Trials

Feasibility of Chemotherapy De-escalation in Early-Stage HER2 Positive Breast Cancer

Birinapant and Carboplatin in Treating Patients and Targeting Recurrent High Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (HGSOC)

Brigatinib Plus Chemotherapy or Local Consolidation Therapy in ALK Positive Advanced Non-small Cell Lung Cancer (BrightStar-2)

Neoadjuvant Nimotuzumab Plus Gemcitabine and Carboplatin in Unresectable Stage III Squamous Cell Lung Carcinoma

APPEAL

NAJSCR

Panitumumab and Pembrolizumab in Combination With Neoadjuvant Chemotherapy for the Treatment of Stage III-IV Triple Negative Breast Cancer

SMMART Adaptive Clinical Treatment (ACT) Trial

NSCLC

Hypofractionated Radiation Therapy After Durvalumab and Chemotherapy for the Treatment of Stage IV Extensive Stage Small Cell Lung Cancer, CASPIAN-RT Trial

APX005M

Alpelisib in Combination With Carboplatin in Patients With Solid Tumors and HPV-Positive Squamous Cell Carcinoma

SGT-53, Carboplatin, and Pembrolizumab for the Treatment of Metastatic Triple Negative Inflammatory Breast Cancer

CRATER

RBD-HPV: Risk-Based De-Intensification for HPV+ HNSCC

LCI-BRE-MTN-NIR-001:Ph I Study of Niraparib in Combo With Standard Chemo in Metastatic Trip Neg Breast Cancer

A Safety and Feasibility Study of AGS-003-LNG for the Treatment of Stage 3 Non Small Cell Lung Cancer

Study of Durvalumab or Durvalumab Plus Chemotherapy in Kras Mutation Positive and PD-L1 High (≥ 50%) NSCLC Patients

Platinum-Based Chemotherapy and Durvalumab for the Treatment of Stage IIIB or IV Non-small Cell Lung Cancer

Paclitaxel + Carboplatin With AVB-S6-500 in Women With Stage III or IV Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Receiving Neoadjuvant Chemotherapy

PANDoRA

Trial Comparing Niraparib-bevacizumab-Dostarlimab and Niraparib-bevacizumab to Standard of Care in Recurrent Ovarian Cancer

Hypofractionated Radiotherapy With Carboplatin and Paclitaxel in Non-Small Cell Lung Cancer

CECAVI

HIPEC

iTRAP

Assessing the Response Rate of Neo-adjuvant Paclitaxel (Taxol) in Nigerian Women With Breast Cancer

PICH

Metformin Hydrochloride, Carboplatin, and Paclitaxel in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Sorafenib and High-Dose Carboplatin, Paclitaxel, and External-Beam Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer

ES01

Chemotherapy and Peripheral Stem Cell Transplantation Followed by Trastuzumab in Treating Women With Metastatic Breast Cancer

A Study of Cisplatin or Carboplatin With Gemcitabine Versus Gemcitabine Alone as Adjuvant Therapy in Patients With Resected or Ablation Intra-Hepatic Cholangiocarcinoma

Doxorubicin and Carboplatin in Treating Patients With Recurrent Ovarian Cancer

Combination of Carboplatin, Eribulin and Veliparib in Stage IV Cancer Patients

Neoadjuvant Bevacizumab and Carboplatin Followed by Concurrent Bevacizumab, Carboplatin and Radiotherapy in the Primary Treatment of Cervix Cancer

Study of Pembrolizumab With Chemotherapy in Patients With Advanced Lymphoma (PembroHeme)

BBBD Followed By Methotrexate and Carboplatin With or Without Trastuzumab in Treating Women With Breast Cancer That Has Spread to the Brain

RELRB1

Chemotherapy for Elderly Patients Diagnosed With Localized HER2 Positive Breast Cancer

Gemcitabine Hydrochloride and Carboplatin With or Without MK-0646 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Testing TH-302, in Combination With Preoperative Chemoradiotherapy, in Esophageal Cancer.

BNC105P Combination Study in Partially Platinum Sensitive Ovarian Cancer Patients

Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor

Combination of Carboplatin, Eribulin Mesylate, and E7449 in BRCA-Related Cancers

Carboplatin, Temozolomide, and Filgrastim in Treating Patients With Newly Diagnosed or Recurrent High-Grade Glioma

Pemetrexed Disodium and Carboplatin or Cisplatin With or Without Erlotinib Hydrochloride in Treating Patient With Stage IV Non-Small Cell Lung Cancer Resistant to First-Line Therapy With Erlotinib Hydrochloride or Gefitinib

Sublingual Anvirzel in Advance Non-Small Cell Lung Cancer (NSCLC)

Abraxane and RT for Non-Small Cell Lung Cancer (NSCLC)

Phase I IGART Study Using Active Breathing Control and Simultaneous Boost for Patients With NSCLC